Article
A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients.
World journal of surgical oncology - 16 Jul 2020
Zhang Xilin, Jiang Yan, Yu Huanming, Xia Hui, Wang Xiang
Abstract excerpt
BACKGROUND: Several genetic driver alterations have been identified in micropapillary lung adenocarcinoma (MPA). However, the frequency of co-alteration of ROS1, EGFR, and EML4-ALK is yet unclear. Herein, we investigated the relationship between clinicopathologic characteristics and well-identified driver mutations of MPA compared with non-micropapillary lung adenocarcinoma (LA). METHODS: Formalin-fixed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
